Arthur C. Butcher - 02 May 2022 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP& Grp Pres, MedSurg & APAC
Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
02 May 2022
Net transactions value
$0
Form type
4
Filing time
01 Sep 2022, 16:24:11 UTC
Previous filing
31 Mar 2022
Next filing
03 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Restricted Stock Units Award $0 +8,407 $0.000000 8,407 02 May 2022 Common Stock 8,407 Direct F1, F2
transaction BSX Stock Option (Right to Buy) Award $0 +22,267 $0.000000 22,267 02 May 2022 Common Stock 22,267 $41.63 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on May 2, 2023, the first anniversary of the date of grant.
F3 Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on May 2, 2023, the first anniversary of the date of grant.